Three of the five tumours with exon 11 mutations were also tested for KIT exon 9 mutations; none had a mutation in line with the mutually exclusive nature of exon 11 and exon 9 KIT mutations in GIST. This evidence concerns the gene KIT and gastrointestinal stromal tumor.